|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4965195A
(en)
|
1987-10-26 |
1990-10-23 |
Immunex Corp. |
Interleukin-7
|
|
US5328988A
(en)
|
1987-10-26 |
1994-07-12 |
Immunex Corporation |
Interleukin-7
|
|
US5714585A
(en)
|
1987-10-26 |
1998-02-03 |
Sterling Winthrop, Inc. |
Antibodies that are immunoreactive with interleukin-7
|
|
US5486359A
(en)
|
1990-11-16 |
1996-01-23 |
Osiris Therapeutics, Inc. |
Human mesenchymal stem cells
|
|
US5674486A
(en)
|
1991-06-25 |
1997-10-07 |
San Diego Regional Cancer Center |
Cancer immunotherapy with carrier cells
|
|
US5981724A
(en)
|
1991-10-25 |
1999-11-09 |
Immunex Corporation |
DNA encoding CD40 ligand, a cytokine that binds CD40
|
|
AU4543193A
(en)
|
1992-06-22 |
1994-01-24 |
Henry E. Young |
Scar inhibitory factor and use thereof
|
|
US7534867B1
(en)
|
1993-05-19 |
2009-05-19 |
Schering Corporation |
Purified mammalian Flt3 ligands; agonists; antagonists
|
|
US5554512A
(en)
|
1993-05-24 |
1996-09-10 |
Immunex Corporation |
Ligands for flt3 receptors
|
|
CZ307995A3
(en)
|
1993-05-24 |
1996-10-16 |
Immunex Corp |
Ligands for flt3 receptors
|
|
US5536657A
(en)
|
1993-07-19 |
1996-07-16 |
Hoffmann-La Roche Inc. |
Recombinant DNA encoding human receptor for interleukin-12
|
|
US5591625A
(en)
|
1993-11-24 |
1997-01-07 |
Case Western Reserve University |
Transduced mesenchymal stem cells
|
|
WO1995027722A1
(en)
|
1994-04-06 |
1995-10-19 |
Immunex Corporation |
Interleukin-15
|
|
US5780268A
(en)
|
1995-12-06 |
1998-07-14 |
Incyte Pharmaceuticals |
Chemokine expressed in a mixed lymphocyte reaction
|
|
US5928906A
(en)
|
1996-05-09 |
1999-07-27 |
Sequenom, Inc. |
Process for direct sequencing during template amplification
|
|
CA2745736C
(en)
|
1996-10-23 |
2016-11-22 |
The Trustees Of The University Of Pennsylvania |
Immunotherapy and improved vaccines
|
|
JP2001522226A
(ja)
|
1997-01-31 |
2001-11-13 |
リサーチ コーポレイション テクノロジーズ インコーポレイテッド |
セミ−同種異系細胞での癌の免疫療法
|
|
US8034332B2
(en)
*
|
1997-04-30 |
2011-10-11 |
Conkwest, Inc. |
Interleukin-secreting natural killer cell lines and methods of use
|
|
US6153182A
(en)
|
1997-12-19 |
2000-11-28 |
Uab Research Foundation |
Lymphotactin as an adjuvant
|
|
US20010023070A1
(en)
|
1998-05-29 |
2001-09-20 |
Reinhard Ebner |
Interleukins-21 and 22
|
|
JP2002516103A
(ja)
|
1998-05-29 |
2002-06-04 |
ヒューマン ジノーム サイエンシーズ， インコーポレイテッド |
インターロイキン２１およびインターロイキン２２
|
|
DE19833476B4
(de)
|
1998-07-24 |
2005-08-25 |
Huss, Ralf, Dr. |
Genetisch modifizierte CD34-Negative, adhärent wachsende hämatopoetische Stammzellen und deren Verwendung in der Gentherapie
|
|
US6392126B1
(en)
|
1999-02-25 |
2002-05-21 |
Pioneer Hi-Bred International, Inc. |
Adenosine deaminase homologues and uses thereof
|
|
US6307024B1
(en)
|
1999-03-09 |
2001-10-23 |
Zymogenetics, Inc. |
Cytokine zalpha11 Ligand
|
|
EP2130919A1
(en)
|
2001-11-05 |
2009-12-09 |
ZymoGenetics, Inc. |
IL-21 antagonists
|
|
US20040076622A1
(en)
|
2002-03-02 |
2004-04-22 |
Board Of Regents, The University Of Texas System |
Local production and/or delivery of anti-cancer agents by stromal cell precursors
|
|
CA2481304A1
(en)
|
2002-03-27 |
2003-10-09 |
Patrick Hwu |
Method for treating cancer in humans
|
|
AU2003273574A1
(en)
|
2002-05-31 |
2003-12-19 |
Osiris Therapeutics, Inc. |
Intraperitoneal delivery of genetically engineered mesenchymal stem cells
|
|
WO2004042023A2
(en)
*
|
2002-11-01 |
2004-05-21 |
Five Prime Therapeutics, Inc. |
Stem cell libraries
|
|
KR101130220B1
(ko)
|
2003-06-27 |
2012-04-13 |
엔씨 메디컬 리서치 가부시키가이샤 |
간엽계 세포를 유효 성분으로 하는 뇌신경 질환 치료용 체내 투여용 약제
|
|
ES2569780T3
(es)
|
2003-06-27 |
2016-05-12 |
DePuy Synthes Products, Inc. |
Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas
|
|
US7052772B2
(en)
|
2003-08-14 |
2006-05-30 |
3M Innovative Properties Company |
Material for packaging electronic components
|
|
US20050037306A1
(en)
|
2003-08-16 |
2005-02-17 |
Tetsuo Nakatsu |
Candle system for enhancing burning and improving volatiles performance and a manufacturing method for the same
|
|
WO2005037218A2
(en)
|
2003-10-17 |
2005-04-28 |
Actis Biologics, Inc. |
Lentiviral vector delivery of il-21 for treatment of cancer
|
|
EP1680138B1
(en)
|
2003-10-17 |
2013-07-17 |
Novo Nordisk A/S |
Combination therapy
|
|
GB0400031D0
(en)
|
2004-01-03 |
2004-02-04 |
Univ Sheffield |
Depression treatment
|
|
US20080253960A1
(en)
|
2004-04-01 |
2008-10-16 |
The Trustees Of The University Of Pennsylvania Center For Technology Transfer |
Lipoprotein-Based Nanoplatforms
|
|
ES2678094T3
(es)
*
|
2004-07-10 |
2018-08-08 |
Fox Chase Cancer Center |
Líneas de células asesinas naturales genéticamente modificadas
|
|
EP1776383B1
(en)
|
2004-07-22 |
2014-08-20 |
Erasmus University Medical Center Rotterdam |
Binding molecules
|
|
DE102005057426A1
(de)
|
2005-11-30 |
2007-05-31 |
Andritz Küsters GmbH & Co. KG |
Unterdruck-Bandfördervorrichtung zum Führen einer laufenden Bahn
|
|
US7833754B2
(en)
|
2006-01-13 |
2010-11-16 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
IL-12 for expression in mammalian cell
|
|
EP2366787B1
(en)
|
2006-01-13 |
2019-12-11 |
The Government Of The U.S.A, As Represented By The Secretary, Dept. Of Health And Human Services |
Codon optimized IL-15 and IL-15R-Alpha genes for expression in mammalian cells
|
|
ATE533782T1
(de)
|
2006-01-13 |
2011-12-15 |
Univ Pennsylvania |
Impfstoffe und immuntherapeutika mit codon- optimiertem il-15 und verwendungsverfahren dafür
|
|
KR100788930B1
(ko)
|
2006-04-18 |
2007-12-27 |
포항공과대학교 산학협력단 |
항암 조성물
|
|
CA2655990A1
(en)
|
2006-06-22 |
2007-12-27 |
Tai June Yoo |
Restoration of hearing loss
|
|
US7993918B2
(en)
|
2006-08-04 |
2011-08-09 |
Anthrogenesis Corporation |
Tumor suppression using placental stem cells
|
|
US8304931B2
(en)
|
2006-12-18 |
2012-11-06 |
Decicon, Inc. |
Configurable power supply integrated circuit
|
|
US8389282B2
(en)
*
|
2007-03-30 |
2013-03-05 |
Memorial Sloan-Kettering Cancer Center |
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
|
|
HUE027603T2
(en)
|
2007-04-20 |
2016-10-28 |
Sigma-Tau Rare Disease Ltd |
Stable, recombinant adenosine deaminase
|
|
PL2147122T3
(pl)
|
2007-04-20 |
2015-05-29 |
Leadiant Biosciences Ltd |
Enzymatyczna terapia przeciwnowotworowa
|
|
US20110038836A1
(en)
*
|
2007-04-23 |
2011-02-17 |
The Board Of Regents, The University Of Texas System |
Device and Method for Transfecting Cells for Therapeutic Use
|
|
US8765462B2
(en)
|
2007-05-04 |
2014-07-01 |
University Health Network |
IL-12 immunotherapy for cancer
|
|
ES2507507T3
(es)
|
2007-05-24 |
2014-10-15 |
Apceth Gmbh & Co. Kg |
Células madre mesenquimales CD34 negativas modificadas genéticamente para el tratamiento de tumores
|
|
EP2034025A1
(en)
|
2007-09-04 |
2009-03-11 |
Freie Universität Berlin |
Inflammation-induced anti-inflammatory gene expression
|
|
US20110020242A1
(en)
|
2007-12-12 |
2011-01-27 |
Gang Zheng |
High-density lipoprotein-like peptide-phospholipid scaffold ("hpps") nanoparticles
|
|
WO2009096701A2
(en)
|
2008-01-28 |
2009-08-06 |
Amorepacific Corporation |
Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
|
|
MX340972B
(es)
|
2008-10-08 |
2016-08-02 |
Intrexon Corp |
Celulas manipuladas por ingenieria que expresan multiples inmunomoduladores, y uso de las mismas.
|
|
WO2010059828A1
(en)
|
2008-11-19 |
2010-05-27 |
Anthrogenesis Corporation |
Amnion derived adherent cells
|
|
JP5727458B2
(ja)
|
2009-04-13 |
2015-06-03 |
アプセト ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフトＡｐｃｅｔｈ Ｇｍｂｈ ＆ Ｃｏ． Ｋｇ |
改変間葉系幹細胞及びそれを使用した腫瘍の治療方法
|
|
JPWO2010128636A1
(ja)
|
2009-05-08 |
2012-11-01 |
日本電気株式会社 |
通信システム、通信装置、通信方法及びプログラム
|
|
WO2011114919A1
(en)
|
2010-03-19 |
2011-09-22 |
Semiconductor Energy Laboratory Co., Ltd. |
Semiconductor device
|
|
WO2012136231A1
(en)
|
2010-09-08 |
2012-10-11 |
Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus |
Interleukin 15 as selectable marker for gene transfer in lymphocytes
|
|
US20140017787A1
(en)
|
2010-10-11 |
2014-01-16 |
Aline M. Betancourt |
Mesenchymal stem cells and related therapies
|
|
EP2694640B1
(en)
|
2011-04-08 |
2017-10-18 |
Baylor College Of Medicine |
Reversing the effects of the tumor microenvironment using chimeric cytokine receptors
|
|
EP3692794A1
(en)
|
2011-09-16 |
2020-08-12 |
Baylor College of Medicine |
Targeting the tumor microenvironment using manipulated nkt cells
|
|
EP2872619B1
(en)
|
2012-07-11 |
2018-02-14 |
Imstem Biotechnology Inc. |
Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
|
|
CN104471059B
(zh)
|
2012-07-12 |
2018-04-17 |
珠海横琴爱姆斯坦生物科技有限公司 |
人胚胎干细胞衍生的间充质样干细胞、方法及其应用
|
|
JP2016524150A
(ja)
|
2013-06-19 |
2016-08-12 |
ユニヴァーシティー オブ マイアミＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｍｉａｍｉ |
乳癌の分類、予測及び処置のための分類システム、方法及びキット
|
|
EP3021853A1
(en)
*
|
2013-07-18 |
2016-05-25 |
Baylor College Of Medicine |
Method of enhancing potency of immune cells
|
|
JP2015030819A
(ja)
|
2013-08-05 |
2015-02-16 |
株式会社ジェイテクト |
アクリルゴム組成物およびこれを備えたシール装置
|
|
AR097570A1
(es)
|
2013-09-06 |
2016-03-23 |
Consejo Nac De Investig Científicas Y Técnicas (Conicet) |
Composiciones y métodos para incrementar la migración de células mesenquimales del estroma hacia tumores
|
|
AU2015217406A1
(en)
|
2014-02-11 |
2016-08-25 |
Celularity Inc. |
Micro-organoids, and methods of making and using the same
|
|
KR101723786B1
(ko)
*
|
2014-03-28 |
2017-04-06 |
가톨릭대학교 산학협력단 |
Ｉｌ―２１을 발현하는 중간엽 줄기세포를 포함하는 ｂ 세포 림프종 예방 또는 치료용 조성물
|
|
JP6468712B2
(ja)
|
2014-03-28 |
2019-02-13 |
大和ハウス工業株式会社 |
通信ユニット
|
|
KR20160011916A
(ko)
|
2014-07-23 |
2016-02-02 |
삼성전자주식회사 |
얼굴 인식을 통한 사용자 식별 방법 및 장치
|
|
WO2016019300A1
(en)
|
2014-07-31 |
2016-02-04 |
Novartis Ag |
Subset-optimized chimeric antigen receptor-containing t-cells
|
|
MX2017001656A
(es)
|
2014-08-08 |
2017-07-24 |
Pharmacyclics Llc |
Combinaciones de inhibidor de tirosina cinasa de bruton y usos de estas.
|
|
US9918718B2
(en)
|
2014-08-08 |
2018-03-20 |
DePuy Synthes Products, Inc. |
Embolic coil delivery system with retractable mechanical release mechanism
|
|
US20170239297A1
(en)
|
2014-08-18 |
2017-08-24 |
Apceth Gmbh & Co. Kg |
Genetically modified mesenchymal stem cells expressing an immune response-stimulating cytokine to attract and/or activate immune cells
|
|
EP3236732B1
(en)
|
2014-12-23 |
2019-12-11 |
Husqvarna AB |
Lawn monitoring and maintenance via a robotic vehicle
|
|
KR20160089688A
(ko)
|
2015-01-20 |
2016-07-28 |
삼성전자주식회사 |
엑스선 영상 장치, 및 그 제어방법
|
|
US20160237407A1
(en)
|
2015-02-17 |
2016-08-18 |
Batu Biologics, Inc. |
Universal donor chimeric antigen receptor cells
|
|
WO2016146819A1
(en)
|
2015-03-18 |
2016-09-22 |
Apceth Gmbh & Co. Kg |
Hypoxia-induced expression of therapeutic proteins in mesenchymal stem cells
|
|
WO2016191283A2
(en)
|
2015-05-22 |
2016-12-01 |
University Of Houston System |
Enzymatic immunomodulation of solid tumors and user thereof
|
|
ES2958720T3
(es)
*
|
2015-06-10 |
2024-02-13 |
Immunitybio Inc |
Células NK-92 modificadas para tratar el cáncer
|
|
US11075843B2
(en)
|
2015-06-30 |
2021-07-27 |
British Telecommunications Public Limited Company |
Model management in a dynamic QOS environment
|
|
JP7033453B2
(ja)
*
|
2015-06-30 |
2022-03-10 |
セレクティス |
特異的エンドヌクレアーゼを使用した遺伝子不活化によってｎｋ細胞の機能性を改善する方法
|
|
EP3316794B1
(en)
|
2015-06-30 |
2021-01-20 |
Smith & Nephew, Inc |
Suture anchor system with threaded plug
|
|
US10829735B2
(en)
|
2015-07-21 |
2020-11-10 |
The Trustees Of The University Of Pennsylvania |
Methods for improving the efficacy and expansion of immune cells
|
|
SG10201913151TA
(en)
*
|
2015-09-09 |
2020-03-30 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Genetic engineering of macrophages for immunotherapy
|
|
CN105206757B
(zh)
|
2015-11-05 |
2016-09-07 |
京东方科技集团股份有限公司 |
有机发光二极管及其制作方法、显示基板和显示装置
|
|
US10008344B2
(en)
|
2015-11-11 |
2018-06-26 |
Htc Corporation |
Switch assembly and hand-held device
|
|
US10533157B1
(en)
*
|
2015-12-03 |
2020-01-14 |
Nantbio, Inc. |
Recombinant NK cells expressing co-stimulatory molecules
|
|
WO2017133175A1
(en)
|
2016-02-04 |
2017-08-10 |
Nanjing Legend Biotech Co., Ltd. |
Engineered mammalian cells for cancer therapy
|
|
CA3012741A1
(en)
|
2016-02-18 |
2017-08-24 |
Pluristem Ltd. |
Methods and compositions for treating cancer and neoplasms
|
|
KR101833971B1
(ko)
|
2016-02-19 |
2018-03-02 |
사회복지법인 삼성생명공익재단 |
중간엽 줄기세포 또는 xcl1을 포함하는 근육질환의 예방 또는 치료용 약학적 조성물
|
|
EP4086285A1
(en)
|
2016-02-25 |
2022-11-09 |
Cell Medica Switzerland AG |
Binding members to pd-l1
|
|
AU2017277499B2
(en)
|
2016-06-07 |
2022-07-28 |
The Pacific Heart, lung & Blood Institute |
Compositions and methods for treating cancer
|
|
CN109562126A
(zh)
|
2016-06-24 |
2019-04-02 |
美商生物细胞基因治疗有限公司 |
嵌合抗原受体(car)、组合物及其使用方法
|
|
CN109715205A
(zh)
|
2016-08-19 |
2019-05-03 |
库瑞瓦格股份公司 |
用于癌症治疗的rna
|
|
WO2018071295A1
(en)
|
2016-10-10 |
2018-04-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for inducible production of anti-inflammatory cytokines
|
|
JP6607179B2
(ja)
|
2016-12-15 |
2019-11-20 |
トヨタ自動車株式会社 |
車両の制御装置
|
|
WO2018161026A1
(en)
|
2017-03-03 |
2018-09-07 |
Obsidian Therapeutics, Inc. |
Il15 compositions and methods for immunotherapy
|
|
CN110913954A
(zh)
|
2017-03-03 |
2020-03-24 |
黑曜石疗法公司 |
免疫疗法的组合物和方法
|
|
WO2018161038A1
(en)
|
2017-03-03 |
2018-09-07 |
Obsidian Therapeutics, Inc. |
Il12 compositions and methods for immunotherapy
|
|
JP2020509773A
(ja)
|
2017-03-17 |
2020-04-02 |
センティ バイオサイエンシズ インコーポレイテッド |
免疫調節性細胞回路
|
|
KR20190141695A
(ko)
|
2017-04-13 |
2019-12-24 |
센티 바이오사이언시스, 인코포레이티드 |
병용 암 면역요법
|
|
AU2018270111B2
(en)
|
2017-05-18 |
2022-07-14 |
Modernatx, Inc. |
Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereof
|
|
CA3116138A1
(en)
*
|
2018-10-17 |
2020-04-23 |
Senti Biosciences, Inc. |
Combinatorial cancer immunotherapy
|
|
US11419898B2
(en)
|
2018-10-17 |
2022-08-23 |
Senti Biosciences, Inc. |
Combinatorial cancer immunotherapy
|
|
CN115851605A
(zh)
*
|
2019-04-18 |
2023-03-28 |
上海交通大学 |
间充质干细胞靶向运输趋化因子和细胞因子的免疫疗法
|
|
WO2021041920A1
(en)
*
|
2019-08-28 |
2021-03-04 |
Senti Biosciences, Inc. |
Combinatorial cancer immunotherapy
|